Ionis - IONS Income before deduction of interest, taxes and amortization
Ionis Pharmaceuticals (IONS) is optimizing the delivery of RNA drugs through diversified networks while maintaining high margins. The current EBITDA_Co metric on GURU.Markets captures liquidity dynamics, where the value is held at 0.00. High clinical trial costs and stringent patents create a significant barrier to entry. Meanwhile, an extensive intellectual property portfolio and partnerships with industry behemoths guarantee a steady stream of royalties.
Summary analytical data breakdowns for Ionis (IONS)
- stock value and consensus price forecast:
- issuer market value details:
- book capitalization information:
- debt level and financial liquidity data:
- earnings and valuation multiples information:
IONS - Net Profit|Expected Net Profit Ionis Pharmaceuticals|IONS - Price to Earnings Ratio|Forward P/E Multiple ionispharma.com|IONS - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio Ionis|IONS - Operating profit EBITDA|Net earnings per share for the last four quarters Ionis|IONS - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months ionispharma.com|IONS - Earnings growth in current year|Earnings growth forecast for next year Ionis Pharmaceuticals
Analysis of all company metrics:IONS - Isis Pharmaceuticals
Finding a balance between cost and business quality requires an analysis of actual cash flow. This indicator measures the volume of cash from core operations before interest and taxes, excluding reporting time lags. For Ionis Pharmaceuticals (IONS), this metric reflects the efficiency of commercializing innovations regardless of economic cycles. The trend in cash inflows confirms the success of clinical trials. Historical EBITDA_Co data allows for the timely detection of capital stagnation.
Who Ionis Pharmaceuticals competes with
Operating income before deduction of amortization Tempus (TEM)|QGEN: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization RGEN (repligen.com)|Avidity Biosciences, Inc. (RNA) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization CRSP (CRISPR Therapeutics Inc)|WGS (Sema4) - Operating profit EBITDA|RARE: Income before deduction of interest, taxes and amortization|Operating profit EBITDA BEAM|Operating profit EBITDA sarepta.com (SRPT)|Profit before payment of interest, taxes and amortization Twist Bioscience, Inc. TWST|Income before deduction of interest, taxes and amortization TXG|NTLA - Profit before payment of interest, taxes and amortization|Stoke Corp (STOK) - Operating profit before deduction of amortization|BLFS: Operating profit EBITDA|wavelifesciences.com (WVE) - Operating profit EBITDA|MAZE (Maze Therapeutics) - Operating profit EBITDA|Operating profit before deduction of amortization Sionna Therapeutics, Inc. (SION)|Operating profit EBITDA PRME|TSHA - Profit before interest, taxes and amortization|uniQure N.V. - Operating profit before deduction of amortization|Operating profit EBITDA meiragtx.com MGTX|RGNX: Operating profit before deduction of amortization|Solid Biosciences Inc - Company profit before taxes, interest and amortization|OCGN: Operating profit EBITDA|PACB - Operating income before deduction of amortization|BNTC (Benitec Biopharma Inc.) - Operating profit EBITDA|Operating profit before deduction of amortization designtx.com (DSGN)|Operating profit EBITDA RCKT|Operating profit EBITDA 4DMT (FDMT)|Profit before payment of interest, taxes and amortization Lexeo Therapeutics, Inc. LXEO|Korro Bio Inc. - Profit before payment of interest, taxes and amortization|EDIT - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization silence-therapeutics.com SLN|PRQR: Operating profit EBITDA|CDXS - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Sangamo|Profit before interest, taxes and amortization Nautilus Biotechnology Inc NAUT|Profit before payment of interest, taxes and amortization Metagenomi, Inc. (MGX)|precisionbiosciences.com - Operating profit before amortization|Profit before payment of interest, taxes and amortization Generation Bio GBIO|Operating income before deduction of amortization Boundless Bio Inc. (BOLD)|Exicure Corp - Operating profit EBITDA|IMNN (Imunon, Inc.) - Operating profit before amortization|phiopharma.com (PHIO) - Profit before payment of interest, taxes and amortization|Operating profit before amortization MBIO|RNAZ (TransCode Therapeutics Inc.) - Operating profit EBITDA|Operating profit EBITDA Bionano|Operating profit EBITDA APDN|Operating income before deduction of amortization bluebird bio, Inc|Profit before payment of interest, taxes and amortization ImmunoPrecise Antibodies Ltd. IPA|omegatherapeutics.com (OMGA) - Profit before interest, taxes and amortization|OMIC - Profit before payment of interest, taxes and amortization|RGLS (Regulus Therapeutics, Inc.) - Operating profit before amortization|SYRS: Operating profit EBITDA|TBIO - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization TRACON Pharmaceuticals|unitybiotechnology.com (UBX) - Operating income before deduction of amortization
